Source: Cell Biochemistry and Function. Unidade: FCF
Subjects: SEROTONINA, METABÓLITOS
ABNT
TOURINO, Melissa Cavalheiro et al. Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor-reactive effect of peripheral blood mononuclear cells. Cell Biochemistry and Function, v. 31, n. 5, p. 361-364, 2013Tradução . . Disponível em: https://doi.org/10.1002/cbf.2980. Acesso em: 23 abr. 2024.APA
Tourino, M. C., Oliveira, E. M. de, Bellé, L. P., Knebel, F. H., Albuquerque, R. C., Dörr, F. A., et al. (2013). Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor-reactive effect of peripheral blood mononuclear cells. Cell Biochemistry and Function, 31( 5), 361-364. doi:10.1002/cbf.2980NLM
Tourino MC, Oliveira EM de, Bellé LP, Knebel FH, Albuquerque RC, Dörr FA, Okada SS, Migliorini S, Soares I da S, Campa A. Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor-reactive effect of peripheral blood mononuclear cells [Internet]. Cell Biochemistry and Function. 2013 ; 31( 5): 361-364.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1002/cbf.2980Vancouver
Tourino MC, Oliveira EM de, Bellé LP, Knebel FH, Albuquerque RC, Dörr FA, Okada SS, Migliorini S, Soares I da S, Campa A. Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor-reactive effect of peripheral blood mononuclear cells [Internet]. Cell Biochemistry and Function. 2013 ; 31( 5): 361-364.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1002/cbf.2980